The transient ischemic attack market comprises medical devices and drugs that aid in treatment of transient ischemic attacks (TIAs), commonly known as mini-strokes. Some key products in this market include anti-platelet drugs such as aspirin and clopidogrel, anticoagulants, statins, blood sugar regulating drugs, and medical devices such as ECG monitors. TIAs have similar symptoms to strokes but the blockage to the brain is only temporary. With early diagnosis and treatment, the risk of future stroke can be reduced significantly. The transient ischemic attack market is witnessing growth due to increasing geriatric population globally as aged people are more prone to develop TIAs.
The Global Transient Ischemic Attack Market is estimated to be valued at USD 1.34 Bn in 2024 and is expected to reach USD 2.03 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Key Takeaways
- Key players operating in the transient ischemic attack market are copyright, Sanofi, Johnson & Johnson, AstraZeneca, Daiichi Sankyo.
- Growing geriatric population suffering from conditions like high blood pressure, diabetes, and cardiac disorders is a major factor driving the demand for Transient Ischemic Attack Market drugs and devices. According to the WHO, the population aged over 60 years is growing at a rate of 3% every year globally.
- Technological advancements are helping in early diagnosis of TIAs. Wearable ECG monitors connected to smartphones can detect abnormal heart rhythms and send real-time data to physicians for prompt treatment. Startups are developing portable devices and apps to diagnose TIAs within minutes at affordable costs.
Market Trends
- Home healthcare trend is on a rise with growing preference for home-based disease management to avoid hospital visits. This is boosting demand for portable monitoring devices that can be used at home settings.
- Personalized medicine is emerging, where treatment strategies are customized as per individual patient's genetic profile and risk factors. This requires development of innovative drugs with reduced side-effects and higher efficacy.
Market Opportunities
- Emerging economies like India, China and Brazil offer high growth potential due to rising healthcare investments, expanding medical insurance coverage and growing medical needs of aging populations.
- TeleStroke programs connecting neurologists to rural primary care centers via telemedicine are an opportunity to make specialized stroke/TIA care accessible to remote areas. This can help in early management of TIAs and prevent permanent disabilities.
Impact of COVID-19 on Transient Ischemic Attack Market Growth
The COVID-19 pandemic has had a significant impact on the transient ischemic attack market. During the initial spread of the virus, many non-essential medical procedures and visits were postponed to focus resources on the emerging crisis. This resulted in fewer transient ischemic attack diagnoses as symptoms were often ignored or left untreated. However, as the virus' impact on healthcare systems became clearer, more efforts were made to continue essential stroke and brain health services virtually or with appropriate safety measures.
Throughout the pandemic, telehealth and remote patient monitoring have played a crucial role in maintaining connections between at-risk patients and medical providers. New digital tools and remote diagnostic methods have helped compensate for disruptions to traditional care models. Still, ongoing virus-related concerns have continued limiting some in-person follow-ups and preventative treatments. Younger patients in particular seem to have experienced reductions in referrals and ongoing care.
Going forward, the aftereffects of the pandemic are anticipated to influence transient ischemic attack incidence and management strategies for years. Areas disproportionately impacted by the virus may see increased risk of future events due to added stressors. Telehealth is also expected to maintain a prominent role within the market. Providers will need to focus on removing barriers to essential services while prioritizing patient and staff safety. Expanded remote monitoring technologies, outreach programs and innovations in home-based diagnostics could help address long-term care gaps from the pandemic's effects.
In terms of geography, North America represents the largest regional market for transient ischemic attacks, driven by major country markets including the United States and copyright. This is attributed to factors including growing elderly population, rising prevalence of risk factors and strong healthcare infrastructure and systems. However, the pandemic disrupted many systems, highlighting the need for improved continuity of care networks.
The Asia Pacific region is anticipated to be the fastest growing market over the forecast period due to increasing awareness, healthcare reforms and economic growth. Countries like China and India are prioritizing improvements to stroke management protocols and expanding insurance coverage. If post-COVID challenges can be adequately addressed, the region may see its growth momentum strengthen further.
Get more insights on : Transient Ischemic Attack Market
Get this Report in Japanese Language: 一過性脳虚血発作市場
Get this Report in Korean Language: 일과성 허혈성 발작 시장
Author Bio:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)